Aspen Pharma Pty Ltd — Endone Oxycodone Hydrochloride 5mg Tablet Blister Pack

Photograph of Endone and Anamorph Blister Sheets

Identifying features

Other
Batch Number CW612

What are the defects?

A report has been received that a strip of 30mg Anamorph tablets may have been present in a box of 5mg Endone, post dispensing.

What are the hazards?

Anamorph tablets are approximately four times the Endone equivalent dose, so there is the potential of serious health risks and overdose, if taken inadvertently.

What should consumers do?

Consumers should visually inspect blister sheets to verify both blister strips contain Endone tablets. If a blister is identified with Anamorph printed on the back, do not use the tablets from that strip. Return strips of incorrect tablets to the chemist or pharmacy from which they were purchased.

Further information is available on the TGA website at: https://www.tga.gov.au/alert/endone-5-mg-tablets

For further information, contact Aspen Pharma by phone on 1300 659 646 or email at medical@aspenpharmacare.com.au

Traders who sold this product

Pharmacies and Chemists

Where the product was sold
Nationally

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category